Integra LifeSciences Holdings Corporation ( IART) - Key Metrics
IART Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.36 | $0.06 | $0.29 | $0.48 |
| 2026Q1 | $5.09 | -$0.06 | $0.13 | -$0.07 |
| 2025Q4 | $5.67 | -$0.02 | $0.15 | -$0.26 |
| 2025Q3 | $5.24 | -$0.07 | $0.53 | $0.34 |
| 2025Q2 | $5.44 | -$6.33 | $0.12 | -$0.15 |
IART Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 74.83 |
| 2026Q1 | 0% | -39.25 |
| 2025Q4 | 0% | -139.86 |
| 2025Q3 | 0% | -51.18 |
| 2025Q2 | 0% | -0.48 |
IART Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.68% | 0% |
| 2026Q1 | -0.70% | 0% |
| 2025Q4 | -2.06% | 0% |
| 2025Q3 | 2.34% | 0% |
| 2025Q2 | -1.20% | 0% |
IART
Price: $13.52
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 405021
Ebitda: 31.0 millionMarket Capitalization: 1.0 billion